Stock code: 688185 Stock abbreviation: CanSino Announcement No.: 2024-050

CanSino Biologics Co., Ltd

Announcement on the Resolution of the Second Meeting of Holders of the 2023 A-share Employee Stock Ownership Plan

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or material omissions in the content of this announcement, and assume legal responsibility for the authenticity, accuracy and completeness of its content in accordance with the law.

1. The convening of the meeting of holders

CanSino Biologics Co., Ltd. (hereinafter referred to as the "Company") held the 2023 A-share employee stock ownership plan for the second time

The meeting was held on November 25, 2024 in the company's conference room by means of on-site and communication voting. The meeting was convened by the Management Committee and presided over by Mr. Liu Ming, a member appointed by Ms. Liu Wei, Director of the Management Committee

There were 161 people and 146 actual attendees, representing 133,525 shares of the 2023 A-share ESOP

, accounting for 96.56% of the voting shares held by the Employee Stock Ownership Plan. The convening, convening and voting procedures of this meeting are in accordance with the relevant provisions of the Company's 2023 A-share Employee Stock Ownership Plan.

2. Deliberations at the meeting of holders

Reviewed and approved the "Proposal on Changing the Members of the Management Committee of the Company's 2023 A-share Employee Stock Ownership Plan".

Case》

After deliberation and voting, Ms. Sui Xiuwen was elected as a member of the Management Committee of the Company's 2023 A-share Employee Stock Ownership Plan

together with Mr. Liu Ming and Mr. Cui Jin to form the Management Committee of the Company's 2023 A-share Employee Stock Ownership Plan, and the term of office is the same as the duration of the Employee Stock Ownership Plan. Ms. Liu Wei ceased to be a member and director of the Management Committee of the Company's 2023 A-share Employee Stock Ownership Plan. Ms. Sui Xiuwen has no relationship with more than 5% of the shareholders of the listed company, the actual controller, the director, supervisor and senior management of the listed company.

Voting result: 133,525 votes in favour, representing 100% of the total number of valid voting shares held by holders attending the meeting of holders; 0 against, representing 0.00% of the total number of valid voting shares held by the holders present at the meeting of holders; 0 abstentions, representing 0.00% of the total number of valid voting shares held by the holders present at the meeting of holders.

On the same day, the company's 2023 A-share employee stock ownership plan management committee held its third meeting to elect Liu Ming

Mr. is the Chairman of the Management Committee of the Company's 2023 A-share Employee Stock Ownership Plan, and his term of office is the same as that of the Company's 2023 A-shares

The duration of the ESOP is the same.

The announcement is hereby made.

Board of Directors of CanSino Biologics Co., Ltd

November 26, 2024